DIC (TSE:4631) has quietly outperformed the broader Japanese market this year, and that steady climb has investors asking whether this specialty chemicals name still offers value after a strong run.
If you are wondering whether DIC is still good value after its recent run, you are not alone. This is exactly the kind of stock where the headline share price does not tell the full story. The share ...
DIC related to cancer is always secondary to a well-defined clinical condition. (See Table 1 for a list of common causes of DIC related to cancer.) This point is important to remember, as treatment of ...
DIC Corporation will participate in CES 2026, one of the world’s leading technology trade shows and showcase prototypes of three innovative products.
This page lists all known medications that could potentially lead to 'Disseminated intravascular coagulation' as a side effect. It's important to note that mild side effects are quite common with ...
Since it was described a half-century ago, the concept of disseminated intravascular coagulation (DIC) and its underlying pathogenesis have taken shape in accordance with the understanding of the ...
The laboratory diagnosis of DIC is difficult because none of the available tests are specific for DIC. In addition, almost all of the routinely available tests address the bleeding problem due to the ...
Disseminated intravascular coagulation (DIC) is a condition that affects your blood’s clotting abilities. It can either set in slowly or happen very suddenly under particular conditions. It’s also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results